Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years…
Scroll below vaccine planning and communication resources to see an article listing.
Both appear to be more than 90 percent effective in clinical trials and could begin to be available before the end of the year.
A year of scientific uncertainty is over. Two vaccines look like they will work, and more should follow.